Search

Your search keyword '"Rosso C."' showing total 1,070 results

Search Constraints

Start Over You searched for: Author "Rosso C." Remove constraint Author: "Rosso C."
1,070 results on '"Rosso C."'

Search Results

1. Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

2. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

5. A translational roadmap for transcranial magnetic and direct current stimulation in stroke rehabilitation: Consensus-based core recommendations from the Third Stroke Recovery and Rehabilitation Roundtable

6. Improvements on Design and Validation of Automotive Steel Wheels

8. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

10. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

11. The Euclid mission: status after launch and early operations

14. Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage

15. Silent sinus syndrome: systematic review and proposal of definition, diagnosis and management

17. Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort

18. A nutrigenetic precision approach for the management of NAFLD

21. T.07.3 PROGNOSTIC VALUE OF LIVER STIFFNESS AND FIB-4 SCORE IN INDIVIDUALS WITH CIRRHOSIS DUE TO NON-ALCOHOLIC FATTY LIVER DISEASE WITHOUT PREVIOUS LIVER DECOMPENSATION

22. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes a pro-tumorigenic inflammatory response

23. Interferon gamma-induced protein 10 levels are associated with insulin resistant components in subjects with non-alcoholic fatty liver disease

24. Social jetlag and mediterranean diet adherence are associated to liver fibrosis in patients with non-alcoholic fatty liver disease

25. Echocardiography-based markers of subclinical cardiac dysfunction in individuals with Non-Alcoholic Fatty Liver Disease and preserved ejection fraction: Interim data from a prospective study

26. Prognostic value of simple non-invasive tests for the risk stratification of hcc development in patients with cirrhosis due to non-alcoholic fatty liver disease

28. Prevalence and predictors of steatotic liver disease and significant liver fibrosis in an integrated hepatological and non-hepatological healthcare pathway model.

29. Impact of sexual dimorphism on liver damage in patients with metabolic-dysfunction associated steatotic liver disease.

31. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD : an individual patient data meta-analysis

34. High degree of consensus achieved regarding diagnosis and treatment of acromioclavicular joint instability among ESA-ESSKA members

35. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach?

36. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach?

40. The role of histidine-rich glycoprotein in non alcoholic steatohepatitis-related experimental liver carcinogenesis

41. Safety and Efficacy of Cangrelor in Acute Stroke Treated with Mechanical Thrombectomy: Endovascular Treatment of Ischemic Stroke Registry and Meta-analysis

42. MiRNome profiling of circulating extracellular vesicles in patients with chronic hepatitis delta treated with pegylated interferon alpha

43. Liver cancer-specific isoform of serine protease inhibitor Kazal for the detection of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

44. Precision rehabilitation for aphasia by patient age, sex, aphasia severity, and time since stroke? A prespecified, systematic review-based, individual participant data, network, subgroup meta-analysis

46. Incidence of clinical outcomes in patients with MASLD and long-term follow up: results from a single center cohort study.

47. The association between non-invasive tests of liver fibrosis and early diastolic dysfunction in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.

48. The use of Controlled Attenuation Parameter for the assessment of treatment response in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease undergoing a lifestyle intervention program.

49. Influence of the MBOAT7 rs641738 polymorphism on the prognosis of patients with metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma.

50. Genome-wide association study of noninvasive scores of fibrotic MASLD in an Italian population.

Catalog

Books, media, physical & digital resources